Vireo Growth Inc. (VREOF) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vireo Growth Inc.  (OTC: VREOF)


Vireo Growth's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vireo Growth's ROI in the second quarter of 2026?
Vireo Growth Inc. recorded a cumulative net loss of $-67 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -8.87%.

Within the Healthcare sector 72 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3096 to 3121.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 151.91 % 276.73 % 302.8 % 323.69 % 262.36 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 893 820 708 602 562
Return On Investment (TTM) -8.87 % -12.17 % -12.77 % -15.21 % -14.02 %
VREOF's Overall Ranking # 3121 # 3096 # # #
Seq. Investment Change TTM 12.28 % 26.22 % 27.88 % 39 % 67.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -67 -82 -68 -63 -42

VREOF Company Profile >> Back to VREOF Roi Comparisons >> See Annual VREOF Return On Investment



Return On Investment VREOF's Ranking
Within: No.
Industry # 18
Sector # 73
Overall # 3121

Return On Investment Statistics
High Average Low
-9.61 %
-32.24 %
-65.65 %
(Jun 30 2026)   (Dec 31 2022)







Financial Statements
Vireo Growth's II. Quarter Investments $ 893 Millions VREOF's Balance sheet
Vireo Growth's II. Quarter Income $ 0 Millions Quarterly VREOF's Income Statement
VREOF's Income by Division See VREOF's Income by Division


VREOF Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2021
Total Investments in Millions 488 243 108 53 70
Y / Y Investment Growth 100.37 % 126.33 % 103.73 % -24.51 % -
Net Income in Millions -68 -28 -26 -42 -23
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.96 % -11.51 % -23.75 % -80.42 % -32.81 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VREOF's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VREOF's Competitors
Subscribers only: Roi for Vireo Growth's Suppliers
Subscribers only: Return On Investment for VREOF's Customers

Other Ratios
VREOF's Roa VREOF's Inventory Turnover Ratio VREOF's Growth Rates VREOF's Dividend Statistics
VREOF's Profitability Ratios VREOF's Asset Turnover Ratio VREOF's Dividend Growth
VREOF's Roe VREOF's Valuation Ratios VREOF's Financial Strength Ratios VREOF's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:44:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.